Shankar B. Kalbhare, Vivek Kumar Redasani, Mandar J. Bhandwalkar, Rohit K. Pawar, Avinash M. Bhagwat
Shankar B. Kalbhare1*, Dr. Vivek Kumar Redasani2, Mandar J. Bhandwalkar3, Rohit K. Pawar3, Avinash M. Bhagwat1
1Assistant Professor, YSPM’s Yashoda Technical Campus, Satara (M.S.) India.
2Director, YSPM’s Yashoda Technical Campus, Satara (M.S.) India.
3Assistant Professor, Late Narayandas Bhawandas Chhabada Institute of Pharmacy, Satara (M.S.) India.
Volume - 11,
Issue - 2,
Year - 2021
The aim of the present research work was to systemically device a model of factors that would yield an optimized release modulating dosage form of an anti-hypertensive agent, losartan potassium, using response surface methodology by employing a 3-factor, 3-level Box-Behnken statistical design. Independent variables studied were the amount of the release retardant polymers – aminated fenugreek gum (X1), aminated tamarind gum (X2) and aminated xanthan gum (X3). The dependent variables were the burst release in 15 min (Y1), cumulative percentage release of drug after 60 min (Y2) and hardness (Y3) of the tablets with constraints on the Y2 = 31–35%. Statistical validity of the polynomials was established. In vitro release and swelling studies were carried out for the optimized formulation and the data were fitted to kinetic equations. The polynomial mathematical relationship obtained Y2=32.91-2.29X1-5.68X2-0.97X3+0.20X1X3-0.005X2X3-0.92X12-1.89X22 explained the main and quadratic effects, and the interactions of factors influencing the drug release from matrix tablets. The adjusted (0.9842) and predicted values (0.9600) of r2 for Y2 were in close agreement. Validation of the optimization study indicated high degree of prognostic ability of response surface methodology. The Box-Behnken experimental design facilitated the formulation and optimization of release modulating matrix systems of losartan potassium.
Cite this article:
Shankar B. Kalbhare, Vivek Kumar Redasani, Mandar J. Bhandwalkar, Rohit K. Pawar, Avinash M. Bhagwat. Role of Aminated derivatives of Natural Gum in Release Modulating Matrix Systems of Losartan Potassium: Optimization of Formulation using Box-Behnken Design. Asian Journal of Pharmaceutical Research. 2021; 11(2):73-4. doi: 10.52711/2231-5691.2021.00015
Shankar B. Kalbhare, Vivek Kumar Redasani, Mandar J. Bhandwalkar, Rohit K. Pawar, Avinash M. Bhagwat. Role of Aminated derivatives of Natural Gum in Release Modulating Matrix Systems of Losartan Potassium: Optimization of Formulation using Box-Behnken Design. Asian Journal of Pharmaceutical Research. 2021; 11(2):73-4. doi: 10.52711/2231-5691.2021.00015 Available on: https://asianjpr.com/AbstractView.aspx?PID=2021-11-2-1
1. Hamid Khan. UHPLC-PDA Method for Simultaneous Determination of Sartans Antihypertensive Drugs. Asian J. Pharm. Ana. 2020; 10(1): 07-10.
2. Indu Sharma, Bharat Parashar, Hitesh Kumar Dhamija, Ritu sharma. An Ayurvedic Arena for Hypertension Treatment. Asian J. Pharm. Res. 2(2): April-June 2012; Page 54-58.
3. Suraj V. Bondre, Rushikesh S. Chavan, Indrayani D. Raut, Shrinivas K. Mohite, Chandrakant S. Magdum. An Overview of Survey on Antihypertensive Drugs. Asian J. Pharm. Res. 2020; 10(3): 160-162.
4. L. Z. Benet, “Biopharmaceutics and Pharmacokinetics,” Annu. Rep. Med. Chem., vol. 6, no. C, pp. 264–273, 1971, doi: 10.1016/S0065-7743(08)60981-1.
5. M. Alonso-Sande, D. Teijeiro-Osorio, C. Remuñán-López, and M. J. Alonso, “Glucomannan, a promising polysaccharide for biopharmaceutical purposes,” Eur. J. Pharm. Biopharm., vol. 72, no. 2, pp. 453–462, 2009, doi: 10.1016/j.ejpb.2008.02.005.
6. P. Bassi and G. Kaur, “Fenugreek gum derivatives with improved bioadhesion and controlled drug release: In vitro and in vivo characterization,” J. Drug Deliv. Sci. Technol., vol. 29, pp. 42–54, 2015, doi: 10.1016/j.jddst.2015.06.006.
7. K. Mali, S. Dhawale, R. Dias, and V. Ghorpade, “Delivery of drugs using tamarind gum and modified tamarind gum: A review,” Bull. Fac. Pharmacy, Cairo Univ., vol. 57, no. 1, pp. 1–24, 2019, doi: 10.21608/bfpc.2019.47260.
8. C. K. Simi and T. E. Abraham, “Physico chemical properties of aminated tamarind xyloglucan,” Colloids Surfaces B Biointerfaces, vol. 81, no. 2, pp. 513–520, 2010, doi: 10.1016/j.colsurfb.2010.07.051.
9. S. N. Jampala, S. Manolache, S. Gunasekaran, and F. S. Denes, “Plasma-enhanced modification of xanthan gum and its effect on rheological properties,” J. Agric. Food Chem., vol. 53, no. 9, pp. 3618–3625, 2005, doi: 10.1021/jf0479113.
10. R. Balwierz, A. Jankowski, A. Jasińska, D. Marciniak, and J. Pluta, “Formulation and evaluation of microspheres containing losartan potassium by spray-drying technique,” Acta Pol. Pharm. - Drug Res., vol. 73, no. 5, pp. 1275–1286, 2016.
11. S. B. Kalbhare, M. J. Bhandwalkar, R. K. Pawar, and A. R. Sagre, “Sodium Alginate cross-linked Polymeric Microbeads for oral Sustained drug delivery in Hypertension : Formulation and Evaluation,” vol. 10, no. 3, pp. 153–157, 2020, doi: 10.5958/2231- 5659.2020.00029.6.
12. N. Ramalingam, C. Binulal, M. Palanivelu, B. Ganesan, and M. Dt, “Preparation and evaluation of losartan potassium,”vol. 7, no. 7, pp. 1098–1115, 2018, doi: 10.20959/wjpps20187-11980.
13. A. Palamakula, M. T. H. Nutan, and M. A. Khan, “Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form,” AAPS PharmSciTech, vol. 5, no. 4, pp. 1–8, 2004, doi: 10.1208/pt050466.
14. S. L. C. Ferreira et al., “Box-Behnken design: An alternative for the optimization of analytical methods,” Anal. Chim. Acta, vol. 597, no. 2, pp. 179–186, 2007, doi: 10.1016/j.aca.2007.07.011.
15. Napa Delhiraj, Sockalingam Anbazhagan. Validated HPTLC Method for the Estimation of Antihypertensive Drugs in Pharmaceutical Combined Dosage Forms. Asian J. Research Chem. 5(11): Nov., 2012; Page 1385-1387.
16. Napa Delhiraj, Sockalingam Anbazhagan. Validated HPTLC Method for the Estimation of Antihypertensive Drugs in Pharmaceutical Combined Dosage Forms. Asian J. Research Chem. 5(11): Nov., 2012; Page 1385-1387.
17. S. Chopra, G. V. Patil, and S. K. Motwani, “Release modulating hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design,” Eur. J. Pharm. Biopharm., vol. 66, no. 1, pp. 73–82, 2007, doi: 10.1016/j.ejpb.2006.09.001.
18. G. Saravanan, V. Alagarsamy, C.R. Prakash, P. Dinesh Kumar, T. Panneer Selvam. Synthesis of Novel Thiazole Derivatives as Analgesic Agents. Asian J. Res. Pharm. Sci. 1(4): Oct.-Dec. 2011; Page 134-138.
19. Somnath M. Kedar, Pallavi M. Chaudhari, Rachana N. Patil. Formulation and Evaluation of Sustain Release Tablet of Salbutamol Sulphate by Wet Granulation Method Using Release Retarding Agent. Research J. Pharm. and Tech. 5(2): Feb. 2012; Page 277-280.
20. Akhil Gupta, Anuj Mittal, Alok Kumar Gupta. Colon Targeted Drug Delivery Systems – A Review. Asian J. Pharm. Res. 1(2): April-June 2011; Page 25-33.
21. Nirmala Rangu, B. Chaitanya Kumari, Ganesh Akula, A Jaswanth. Formulation and Evaluation of Metoprolol Orodispersible Tablets by Super Disintegration Method. Asian J. Pharm. Res. 2018; 8(3):119-124. doi: 10.5958/2231-5691.2018.00021.7.
22. M. R. S. Aglawe Sachin B. Gayke A. U., Metkar P. S., Sancheti V.P., Palghadmal P.S., “Formulation and Evaluation of Losartan Potassium Microspheres By,” Indo Am. J. Pharm. Res., vol. 7, no. 09, pp. 735–743, 2017.
23. P. Yeole, U. Galgatte, I. Babla, and P. Nakhat, “Design and evaluation of Xanthan gumbased sustained release matrix tablets of diclofenac sodium,” Indian J. Pharm. Sci., vol. 68, no. 2, pp. 185–189, 2006.
24. Rutuja S. Shah, Rutuja R. Shah, Manoj M. Nitalikar, Chandrakant S. Magdum. Microspheres by Spray Drying: An Approach to Enhance Solubility of Bicalutamide. Asian J. Pharm. Res. 2017; 7(3): 183-188. doi: 10.5958/2231-5691.2017.00028.4
25. G. E. P. Box and K. B. Wilson, “On the Experimental Attainment of Optimum Conditions,” J. R. Stat. Soc. Ser. B, vol. 13, no. 1, pp. 1–38, 1951, doi: 10.1111/j.2517- 6161.1951.tb00067.x.
26. S. Dey, S. Pramanik, and A. Malgope, “Formulation and Optimization of Sustained Release Stavudine Microspheres Using Response Surface Methodology,” ISRN Pharm., vol. 2011, pp. 1–7, 2011, doi: 10.5402/2011/627623.